Concentrations of AB-CHMINACA and AB-PINACA and driving behavior in suspected impaired driving cases

Journal of Analytical Toxicology

Volumn 39, Issue 8, 2015, Pages 642-647

  Peterson, Brianna L ^a   Couper, Fiona J ^a  

^a Washington State Patrol   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 FLUOROPENTYL) 3 (1 NAPHTHOYL)INDOLE; 1 BUTYL 3 (1 NAPHTHOYL)INDOLE; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; CANNABINOID; N (1 AMINO 3 METHYL 1 OXOBUTAN 2 YL) 1 (CYCLOHEXYLMETHYL) 1H INDAZOLE 3 CARBOXAMIDE; N (1 AMINO 3 METHYL 1 OXOBUTAN 2 YL) 1 PENTYL 1H INDAZOLE 3 CARBOXAMIDE; UNCLASSIFIED DRUG; [1 (5 FLUOROPENTYL) 1H INDAZOLE 3 YL](NAPHTHALENE 1 YL)METHANONE; INDAZOLE DERIVATIVE; N-(1-(AMINOCARBONYL)-2-METHYLPROPYL)-1-(CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE; N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE; VALINE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANNABIS USE; CONFUSION; COORDINATION DISORDER; DRIVER; DRIVING ABILITY; FEMALE; HUMAN; LAW ENFORCEMENT; LETHARGY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; NYSTAGMUS; SLURRED SPEECH; YOUNG ADULT; ADOLESCENT; ANALOGS AND DERIVATIVES; BEHAVIOR; BLOOD; CAR DRIVING; CASE REPORT; MIDDLE AGED;

ADOLESCENT; ADULT; AUTOMOBILE DRIVING; BEHAVIOR; FEMALE; HUMANS; INDAZOLES; MALE; MIDDLE AGED; VALINE; YOUNG ADULT;

EID: 84943759712     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkv091     Document Type: Article

References (19)

1. US Department of Justice, Drug Enforcement Administration. (2014) Schedules of controlled substances: temporary placement of three synthetic cannabinoids into schedule I. Docket DEA-402. Federal Registry, 79, 75767-75771.
2. Brents, L.K., Prather, P.L. (2014) The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Drug Metabolism Review, 46, 72-85.
3. US Department of Justice, Drug Enforcement Administration. (2014) Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Docket DEA-402. Federal Registry, 80, 5042-5047.
4. Forensic Drug Review. (2015) Cayman Chemical. http://forensicdrugreview.com/10 (accessed March 3, 2015).
5. Behonick, G., Shanks, K.G., Fichau, D.J., Mathur, G., Lynch, C.F., Nashelsky, M. et al. (2014) Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22. Journal of Analytical Toxicology, 38, 559-562.
6. Stuster, J.W., Burns, M.A. (1998) Validation of the standardized field sobriety test battery at BACs less than 0.10 percent. U.S. Department of Transportation, NHTSA technical report no. DOT-HS-808-839, Washington, DC.
7. Drug evaluation and classification training 'The Drug Recognition Expert School' Administrator's guide (2010 ed.). U.S. Department of Transportation, NHTSA report no. DOT-HS172A R01/10, Washington, DC.
8. Couper, F.J., Logan, B.K. (2004) Drugs and human performance fact sheets. U.S. Department of Transportation, NHTSA technical report no. DOT HS 809 725, Washington, DC.
9. Musshoff, F., Madea, B., Kernbach-Wighton, G., Bicker, W., Kneisel, S., Hutter, M. et al. (2014) Driving under the influence of synthetic cannabinoids ('Spice'): a case series. International Journal of Legal Medicine, 128, 59-64.
10. Yeakel, J.K., Logan, B.K. (2013) Blood synthetic cannabinoid concentrations in cases of suspected impaired driving. Journal of Analytical Toxicology, 37, 547-551.
11. Louis, A., Peterson, B.L., Couper, F.J. (2013) XLR-11 and UR-144 in Washington state and state of Alaska driving cases. Journal of Analytical Toxicology, 38, 563-568.
12. Papafotiou, K., Carter, J.D., Stough, C. (2005) The relationship between performance on the standardised field sobriety tests, driving performance and the level of THC in blood. Forensic Science International, 155, 172-178.
13. Bosker, W.M., Theunissen, E.L., Conen, S., Kuypers, K.P., Jeffery, W.K., Walls, H.C. et al. (2012) A placebo-controlled study to assess SFSTs performance during alcohol and cannabis intoxication in heavy cannabis users and point of collection testing devices for detecting THC in oral fluid. Psychopharmacology, 223, 439-446.
14. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
15. Compton, D.R., Rice, K.C., DeCostra, B.R., Razdan, R.K., Melvin, L.S., Johnson, M.R. et al. (1993) Cannabinoid-structure-activity relationships:correlation of receptor binding and in vivo activities. The Journal of Pharmacology and Experimental Therapeutics, 265, 218-226.
16. Gurney, S.M.R., Scott, K.S., Kacinko, S.L., Presley, B.C., Logan, B.K. (2014) Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Science Review, 26, 53-78.
17. Castaneto, M.S., Gorelick, D.A., Desrosiers, N.A., Hartman, R.L., Pirard, S., Huestis, M.A. (2014) Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol Dependence, 144, 12-41.
18. Karinen, R., Tuv, S.S., Oiestad, E.L., Vindenes, V. (2015) Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids. Forensic Science International, 246, 98-103.
19. Couper, F.J., Peterson, B.L. (2014) The prevalence of marijuana in suspected impaired driving cases in Washington state. Journal of Analytical Toxicology, 38, 569-574.